Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:01:45 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PULM - PULMATRIX INCORPORATED - http://www.pulmatrix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PULM - Q0.12.03·2.081.12.06-0.01-0.51.32122.06  2.06  2.063.14  1.5510:38:35Mar 2815 min RT 2¢

Recent Trades - Last 10 of 12
Time ETExPriceChangeVolume
10:38:35Q2.07-0.021
09:59:55Q2.06-0.031
09:59:31Q2.130.041
09:55:29Q2.01-0.0815
09:30:00Q2.06-0.031
09:30:00Q2.06-0.01100
09:30:00Q2.06-0.036
09:30:00Q2.06-0.0389
09:30:00Q2.06-0.0355
09:30:00Q2.06-0.0355

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-28 09:05U:PULMNews ReleasePulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update
2024-01-08 09:00U:PULMNews ReleasePulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
2023-11-09 09:05U:PULMNews ReleasePulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update
2023-09-19 09:05U:PULMNews ReleasePulmatrix Announces FDA Acceptance of IND Application for PUR3100 to Treat Acute Migraine
2023-08-23 09:05U:PULMNews ReleasePulmatrix Announces Publication on Physiologically Based Pharmacokinetic Modelling of Potential Drug-Drug Interactions with PUR1900, Orally Inhaled Itraconazole
2023-08-10 09:05U:PULMNews ReleasePulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update
2023-07-11 09:05U:PULMNews ReleasePulmatrix Announces Submission of IND Application to FDA to Initiate a Phase 2 Trial of Investigational Drug PUR3100 to Treat Acute Migraine
2023-06-15 09:20U:PULMNews ReleasePulmatrix Presents PUR3100 Phase 1 Data at the 65th Annual Meeting of the American Headache Society
2023-05-24 09:05U:PULMNews ReleasePulmatrix Selected to Present at the Annual Biotechnology Innovation Organization (BIO) International Convention
2023-05-12 09:05U:PULMNews ReleasePulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
2023-05-02 09:05U:PULMNews ReleasePulmatrix Supports World Asthma Day 2023